probenecid has been researched along with Malignant Melanoma in 2 studies
Probenecid: The prototypical uricosuric agent. It inhibits the renal excretion of organic anions and reduces tubular reabsorption of urate. Probenecid has also been used to treat patients with renal impairment, and, because it reduces the renal tubular excretion of other drugs, has been used as an adjunct to antibacterial therapy.
probenecid : A sulfonamide in which the nitrogen of 4-sulfamoylbenzoic acid is substituted with two propyl groups.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Human malignant melanoma is characterised by unresponsiveness to conventional chemotherapy." | 1.30 | Possible role of the multidrug resistance-associated protein (MRP) in chemoresistance of human melanoma cells. ( Berger, W; Elbling, L; Hauptmann, E; Kokoschka, EM; Micksche, M; Vetterlein, M, 1997) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Berger, W | 1 |
| Hauptmann, E | 1 |
| Elbling, L | 1 |
| Vetterlein, M | 1 |
| Kokoschka, EM | 1 |
| Micksche, M | 1 |
| Molinari, A | 1 |
| Calcabrini, A | 1 |
| Meschini, S | 1 |
| Stringaro, A | 1 |
| Del Bufalo, D | 1 |
| Cianfriglia, M | 1 |
| Arancia, G | 1 |
2 other studies available for probenecid and Malignant Melanoma
| Article | Year |
|---|---|
Possible role of the multidrug resistance-associated protein (MRP) in chemoresistance of human melanoma cells.
Topics: Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Antineoplastic Agents; ATP-Binding Cass | 1997 |
Detection of P-glycoprotein in the Golgi apparatus of drug-untreated human melanoma cells.
Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Cell Compartmentation | 1998 |